Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, May 22, 2015, 89 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,297.00 to $237,892,500.00.

Highlighted Stocks Traded by Insiders:

Acacia Research Corporation (ACTG) - FREE Research Report

Haynes Clayton J, who is Cfo at Acacia Research Corporation, sold 14,000 shares at $10.39 on May 22, 2015. Following this transaction, the Cfo owned 120,573 shares meaning that the stake was reduced by 10.4% with the 14,000-share transaction.

Treska Edward Joseph, who is Sr. VP, GC & Secretary at Acacia Research Corporation, sold 7,786 shares at $10.39 on May 22, 2015. Following this transaction, the Sr. VP, GC & Secretary owned 77,941 shares meaning that the stake was reduced by 9.08% with the 7,786-share transaction.

Vella Matthew, who is CEO & President at Acacia Research Corporation, sold 9,437 shares at $10.39 on May 22, 2015. Following this transaction, the CEO & President owned 245,884 shares meaning that the stake was reduced by 3.7% with the 9,437-share transaction.

The shares most recently traded at $10.06, down $0.33, or 3.32% since the insider transaction. Historical insider transactions for Acacia Research Corporation go as follows:

  • 4-Week # shares sold: 40,660
  • 12-Week # shares sold: 40,660
  • 24-Week # shares sold: 40,660

The average volume for Acacia Research Corporation has been 542,900 shares per day over the past 30 days. Acacia Research Corporation has a market cap of $527.3 million and is part of the services sector and diversified services industry. Shares are down 39.02% year-to-date as of the close of trading on Friday.

Acacia Research Corporation, through its subsidiaries, invests in, develops, licenses, and enforces patented technologies in the United States. The stock currently has a dividend yield of 4.84%. Currently, there are 4 analysts who rate Acacia Research Corporation a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACTG - FREE

TheStreet Quant Ratings

rates Acacia Research Corporation as a

sell

. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full

Acacia Research Corporation Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

American Capital Senior Floating (ACSF) - FREE Research Report

Crawford Gilbert, who is Director at American Capital Senior Floating, bought 1,000 shares at $13.29 on May 22, 2015. Following this transaction, the Director owned 6,000 shares meaning that the stake was boosted by 20% with the 1,000-share transaction.

The shares most recently traded at $13.25, down $0.04, or 0.28% since the insider transaction. Historical insider transactions for American Capital Senior Floating go as follows:

  • 4-Week # shares bought: 1,000
  • 12-Week # shares bought: 2,000
  • 24-Week # shares bought: 5,000

The average volume for American Capital Senior Floating has been 37,200 shares per day over the past 30 days. American Capital Senior Floating has a market cap of $133.0 million and is part of the financial sector and financial services industry. Shares are up 9.83% year-to-date as of the close of trading on Friday.

American Capital Senior Floating, Ltd. is a close ended fixed income mutual fund launched by American Capital Asset Management, LLC. The fund is managed by American Capital ACSF Management, LLC. It invests in fixed income markets of the United States. The stock currently has a dividend yield of 8.75%. Currently, there are 3 analysts who rate American Capital Senior Floating a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACSF - FREE

TheStreet Quant Ratings

rates American Capital Senior Floating as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full

American Capital Senior Floating Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Genpact (G) - FREE Research Report

Guaglianone Victor, who is SVP & General Counsel at Genpact, sold 13,850 shares at $23.30 on May 22, 2015. Following this transaction, the SVP & General Counsel owned 30,251 shares meaning that the stake was reduced by 31.41% with the 13,850-share transaction.

The shares most recently traded at $22.53, down $0.77, or 3.43% since the insider transaction. Historical insider transactions for Genpact go as follows:

  • 4-Week # shares sold: 13,850
  • 12-Week # shares sold: 13,850
  • 24-Week # shares sold: 39,193

The average volume for Genpact has been 640,300 shares per day over the past 30 days. Genpact has a market cap of $5.0 billion and is part of the services sector and diversified services industry. Shares are up 20.76% year-to-date as of the close of trading on Friday.

Genpact Limited provides business process outsourcing and information technology services worldwide. The company has a P/E ratio of 27.2. Currently, there are 5 analysts who rate Genpact a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on G - FREE

TheStreet Quant Ratings

rates Genpact as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Genpact Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.